These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3008847)

  • 1. Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulation.
    Snyder RA; Wintroub BU
    Biochim Biophys Acta; 1986 May; 871(1):1-5. PubMed ID: 3008847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human platelet angiotensin I-processing system. Identification of components and inhibition of angiotensin-converting enzyme by product.
    Snyder RA; Watt KW; Wintroub BU
    J Biol Chem; 1985 Jul; 260(13):7857-60. PubMed ID: 2989263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibition of angiotensin-converting enzyme by [des-Pro3]-bradykinin or "converstatin" in comparison with Captopril.
    Okuda M; Arakawa K
    J Biochem; 1985 Sep; 98(3):621-8. PubMed ID: 3003038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiotensin-converting enzyme by angiotensin I analogue peptide inhibitors. A kinetic study.
    Páldi A; Móra M; Bajusz S; Gráf L
    Int J Pept Protein Res; 1987 Jun; 29(6):746-54. PubMed ID: 3040610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic formation of angiotensins II and III in the hindlimb circulation of dogs.
    Metting PJ; Britton SL
    Can J Physiol Pharmacol; 1987 Apr; 65(4):544-9. PubMed ID: 3038284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme.
    Krebs LT; Hanesworth JM; Sardinia MF; Speth RC; Wright JW; Harding JW
    J Pharmacol Exp Ther; 2000 Apr; 293(1):260-7. PubMed ID: 10734177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human angiotensin I competes with two non-thiol converting enzyme inhibitors (CGS 13934 & MK-422) to inhibit the angiotensin-converting enzyme activity of human plasma.
    Chen DS; Nussberger J; Brunner HR; Waeber B
    J Pharm Pharmacol; 1984 Oct; 36(10):707-8. PubMed ID: 6150096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of prostacyclin generation by angiotensin converting enzyme related substances in cultured human vascular endothelial cells.
    Nakagawa M; Sawada S; Toyoda T; Takamatsu H; Tsuji H; Ijichi H
    Clin Exp Hypertens A; 1987; 9(2-3):405-8. PubMed ID: 3038403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin I converting enzyme of rat intestinal and vascular surface membrane.
    Ward PE; Sheridan MA
    Biochim Biophys Acta; 1982 May; 716(2):208-16. PubMed ID: 6284250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II's role in mediating angiotensin I- and tetradecapeptide-induced steroidogenesis by rat glomerulosa cells.
    Braley LM; Menachery A; Williams GH
    Endocrinology; 1981 Sep; 109(3):960-5. PubMed ID: 7021132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin I-converting enzyme from guinea pig lung and serum. A comparison of some kinetic and inhibition properties.
    Lanzillo JJ; Fanburg BL
    Biochim Biophys Acta; 1976 Aug; 445(1):161-8. PubMed ID: 182273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin generation by cultured human vascular endothelial cells with reference to angiotensin I-converting enzyme.
    Sawada S; Toyoda T; Takamatsu H; Niwa I; Maebo N; Tsuji H; Nakagawa M; Ijichi H
    Jpn Circ J; 1986 Mar; 50(3):242-7. PubMed ID: 3016357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme, bradykinin, angiotensin, and cerebral vessel reactivity.
    Whalley ET; Wahl M; Sampaio CA
    Hypertension; 1983; 5(6 Pt 3):V34-7. PubMed ID: 6317557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of (Des-Asp1)angiotensin I as a precursor for (Des-Asp1)angiotensin II ("Angiotensin III").
    Tsai BS; Peach MJ; Khosla MC; Bumpus FM
    J Med Chem; 1975 Dec; 18(12):1180-3. PubMed ID: 172631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for bradykinin potentiation by angiotensin congeners in conscious rats.
    Textor SC; Brunner H; Gavras H
    Am J Physiol; 1981 Feb; 240(2):H255-61. PubMed ID: 6258451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. des-Asp-angiotensin I: its identification in rat blood and confirmation as a substrate for converting enzyme.
    Garcia Del Rio C; Smellie WS; Morton JJ
    Endocrinology; 1981 Feb; 108(2):406-12. PubMed ID: 6256150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.